13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 88 holding rows worth $3,750,533,000.
- Accession
- 0001104659-22-091331
- Filer
- CIK 1346824
- Filed
- 2022-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 88 entries on the cover page, a total value of $3,750,533,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,750,535,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 7,567,900 | $703,512,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 727,024 | $148,269,000 | thousands by filing date | |
| CYTEK BIOSCIENCES INC | 23285D109 | COMMON STOCK | 13,381,054 | $143,578,000 | thousands by filing date | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 8,263,982 | $129,166,000 | thousands by filing date | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 7,040,622 | $126,027,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 4,922,941 | $119,283,000 | thousands by filing date | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 8,670,644 | $105,869,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 4,581,203 | $99,687,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 21,741,458 | $97,837,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 7,805,129 | $96,159,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 10,230,274 | $94,528,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 4,417,259 | $90,996,000 | thousands by filing date | |
| Veru Inc | 92536C103 | Common Stock | 7,900,000 | $89,270,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 5,208,911 | $80,842,000 | thousands by filing date | |
| PEPGEN INC COM | 713317105 | Stock | 8,131,952 | $80,750,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 9,011,651 | $62,090,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 4,398,453 | $61,403,000 | thousands by filing date | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 9,003,018 | $61,311,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 2,075,000 | $55,942,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 17,202,009 | $55,907,000 | thousands by filing date | |
| VOR BIOPHARMA INC | 929033108 | COM | 11,120,973 | $55,271,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 4,264,144 | $53,771,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 7,236,454 | $51,741,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 4,898,373 | $48,886,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 30,126,299 | $46,696,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 1,310,289 | $46,437,000 | thousands by filing date | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 9,770,773 | $45,923,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 3,584,478 | $45,523,000 | thousands by filing date | |
| RXSIGHT INC | 78349D107 | COM | 3,052,796 | $42,983,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 896,724 | $42,389,000 | thousands by filing date | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 13,150,849 | $39,716,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 2,000,000 | $37,980,000 | thousands by filing date | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 7,670,793 | $35,439,000 | thousands by filing date | |
| ICOSAVAX INC | 45114M109 | COM | 5,963,565 | $34,172,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 2,167,391 | $31,492,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,186,636 | $30,613,000 | thousands by filing date | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 3,748,389 | $29,050,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 2,107,149 | $28,994,000 | thousands by filing date | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 3,370,506 | $26,526,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 7,782,669 | $25,060,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 5,914,252 | $24,485,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 1,710,265 | $24,371,000 | thousands by filing date | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 1,578,820 | $21,488,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 5,100,000 | $21,369,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 4,871,067 | $20,215,000 | thousands by filing date | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 3,551,508 | $19,995,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,805,045 | $19,271,000 | thousands by filing date | |
| HILLEVAX INC | 43157M102 | COM | 1,760,019 | $19,237,000 | thousands by filing date | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 476,380 | $19,217,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC | 69945Q105 | COM | 6,175,038 | $18,957,000 | thousands by filing date | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 4,291,881 | $17,554,000 | thousands by filing date | |
| DA32 LIFE SCNCE TEC ACQSTN C | 23312M106 | CLASS A COM | 1,500,000 | $14,535,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 3,307,203 | $13,923,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 2,246,503 | $13,816,000 | thousands by filing date | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 5,014,687 | $12,637,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 1,250,000 | $12,375,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 5,600,000 | $11,648,000 | thousands by filing date | |
| LIANBIO ADR | 53000N108 | COM | 4,622,574 | $9,985,000 | thousands by filing date | |
| FRAZIER LIFESCIENCES ACQU CORP UNIT EXP 120925 | G3710A121 | Stock | 1,000,000 | $9,870,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITN CORP | G31658100 | CLASS A ORD SHS | 1,000,000 | $9,720,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 549,055 | $9,197,000 | thousands by filing date | |
| IO BIOTECH INC | 449778109 | COM | 1,857,755 | $8,676,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 12,367,873 | $7,614,000 | thousands by filing date | |
| 5 01 ACQUISITION CORP | 33836P105 | CMN | 750,000 | $7,425,000 | thousands by filing date | |
| SYNLOGIC INC | 87166L100 | COM | 5,825,858 | $6,700,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 2,589,904 | $6,371,000 | thousands by filing date | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 756,821 | $6,357,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 625,000 | $6,225,000 | thousands by filing date | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 6,991,003 | $6,082,000 | thousands by filing date | |
| BIOMEA FUSION INC | 09077A106 | CMN | 500,000 | $5,990,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 1,878,000 | $5,728,000 | thousands by filing date | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 1,649,711 | $4,817,000 | thousands by filing date | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 383,028 | $4,719,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 1,987,589 | $3,180,000 | thousands by filing date | |
| ENTERA BIO LTD | M40527109 | SHS | 2,353,000 | $3,129,000 | thousands by filing date | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 1,261,435 | $3,128,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 1,031,805 | $2,941,000 | thousands by filing date | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 760,857 | $2,283,000 | thousands by filing date | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 953,393 | $2,269,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 1,726,019 | $2,071,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 1,031,482 | $2,022,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 3,040,885 | $1,776,000 | thousands by filing date | |
| CVRX INC | 126638105 | COMMON STOCK | 275,000 | $1,653,000 | thousands by filing date | |
| SENSEI BIOTHERAPEUTICS INC | 81728A108 | COM | 723,549 | $1,642,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 233,793 | $952,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 450,141 | $918,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 559,600 | $515,000 | thousands by filing date | |
| CALADRIUS BIOSCIENCES INC | 128058203 | COM NEW | 752,500 | $399,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-22-091331 | this filing | 2022-08-15 | acceptance time not in the bulk data set |